ESTIV Congress 2024

Dear colleagues and delegates,

The 22 ^nd International Congress of the European Society of Toxicology In Vitro (ESTIV 2024) is set to convene in the historic and picturesque city of Prague from June 3-6, 2024. Centered around the pivotal theme, ‘The Application of NAMs in Drug Discovery and Drug and Chemical Safety Assessment,’ the congress promises to be a comprehensive platform for professionals to showcase and discuss the latest advancements and research in the field.

The congress will commence with a pre-congress workshop titled ‘How to write and manage a successful EU Horizon proposal: From initial idea to execution.‘ This session, organized in collaboration with the EU H2020 granted project ONTOX, aims to provide invaluable insights and guidance on navigating the complexities of EU Horizon proposals.

Attendees can look forward to an extensive scientific program featuring over 18 scientific sessions, complemented by dedicated lunch sessions, industry-sponsored sessions, and an insightful post-congress workshop facilitated by AFSA Masterclass and EPISKIN Academy. These sessions are meticulously designed to cater to a wide spectrum of interests and specializations within the realm of in vitro toxicology.

Participants and interested parties are encouraged to visit the ESTIV 2024 Congress web page for a detailed overview of the program, alongside pertinent information regarding the registration process. The ESTIV 2024 Congress in Prague stands as a significant occasion for professionals, researchers, and industry leaders to converge, share knowledge, and collaboratively advance the application of non-animal methodologies in drug discovery and safety assessment

The Congress Committees of the ESTIV 2024 Congress warmly welcome you in Prague and look forward to seeing many colleagues working in the area of in vitro and in silico toxicology and pharmacology reuniting!

Helena Kandarova and Clive Roper